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Background/aim: This study aimed to investigate the consistency between stroke and general neurologists in subtype assignment using
the Trial of ORG-10172 in Acute Stroke Treatment (TOAST) and Causative Classification of Stroke (CCS) systems.
Materials and methods: Fifty consecutive acute ischemic stroke patients admitted to the stroke unit were recruited. Patients were
classified by two stroke and two general neurologists, each from different medical centers, according to TOAST followed by the CCS.
Each neurologist was assessed for consistency and compliance in pairs. Concordance among all four neurologists was investigated and
evaluated using the kappa (ĸ) value.
Results: The kappa (ĸ) value of diagnostic compliance between stroke neurologists was 0.61 (95% CI: 0.45–0.77) for TOAST and 0.78
(95% CI: 0.62–0.94) for CSS-5. The kappa (ĸ) value was 0.64 (95% CI: 0.48–0.80) for TOAST and 0.75 (95% CI: 0.60–0.91) for CCS-5 for
general neurologists. Compliance was moderate [ĸ: 0.59 (95% CI: 0.52–0.65)] for TOAST and was strong [ĸ: 0.75 (95% CI: 0.68–0.81)]
for CCS-5 for all 4 neurologists. ‘Cardioembolism’ (91.04%) had the highest compliance in both systems. The frequency of the group
with ‘undetermined etiologies’ was less in the CCS (26%) compared to TOAST.
Conclusion: The CCS system improved compliance in both stroke and general neurologists compared with TOAST. This suggests that
the automatic, evidence-based, easily reproducible CCS system was superior to the TOAST system.
Key words: TOAST, CCS, ischemic stroke, etiology

1. Introduction
Ischemic stroke (IS) is one of the most common
heterogeneous diseases known to be caused by multiple
potential etiologies and can occur in many different
etiological combinations in parallel with advances in
diagnostic technologies (1,2). It is not possible to recognize
and treat such a complicated disease without using a
functional classification system. In addition, a functional
classification system is indispensable for patient selection
for clinical trials, phenotyping, and evaluation of prognosis
for genetic and epidemiological studies (2).
TOAST (Trial of ORG-10172 in Acute Stroke
Treatment) and the CCS (Causative Classification of Stroke)
are two well-known systems for classifying IS (Table 1)

(3–7). TOAST, which is one of the traditional classification
systems and has been used for over 20 years without
losing its importance, gives no idea about what plays the
predominant role when there is more than one etiological
cause. Almost half of the stroke patients are assigned to
the ‘undetermined etiologies’ group by the TOAST system
when more than one possible etiology is defined as the
stroke mechanism (4–6). Indeed, IS can often be the final
result of multiple abnormalities, and treatment decisions
require a more comprehensive assessment, such as that
provided by the CCS (8). The CCS, one of the modern
classification systems, is a semiautomatic classification
system that is freely available to anyone with an Internet
connection (6). The main objective of the CCS is to reduce
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Table 1. TOAST and CCS classification systems and subgroups.
TOAST
Large artery atherosclerosis

CCS
5 main subtypes

8 main subtypes

16 subtypes

Supraaortic
Large artery atherosclerosis

Supraaortic
Large artery atherosclerosis

Supraaortic
Large artery atherosclerosis

Probable - Possible
Cardiac embolism

Evident - Probable - Possible
Cardioaortic embolism

Cardioaortic embolism

Small arterial occlusion

Small arterial occlusion

Other reasons detected

Other reasons detected

Undetermined

Undetermined

Undetermined

Probable - Possible
Small vessel occlusion

Evident - Probable - Possible

Probable - Possible
Other reasons detected

Small arterial occlusion
Evident - Probable - Possible

Probable - Possible
Undetermined

Cardioaortic embolism

Other reasons detected
Evident - Probable - Possible

Cryptogenic embolism

Cryptogenic embolism

Cryptogenic embolism

Idiopathic

Other cryptogenic

Other cryptogenic

Other cryptogenic

Incomplete evaluation

Incomplete evaluation

Incomplete evaluation

Incomplete evaluation

Unclassified
(multiple etiologies)

Unclassified
(multiple etiologies)

Unclassified
(multiple etiologies)

Unclassified
(multiple etiologies)

The CCS distributes ischemic stroke into 5 major etiologic groups such as the TOAST system (CCS-5). If the ‘Undetermined’ group
is evaluated by distribution into three subgroups in the CCS, there will be 8 subgroups for the CCS (CCS-8). If the other four major
subgroups are defined at three points, which are obvious, probable, and possible, according to the weight of causal evidence (the risk of
primary stroke associated with each cause), the CCS-16 system may be mentioned. Thus, stroke mechanisms are arranged in order of
greatest to smallest and the most possible cause of stroke can be found (4–6).

the limitations of the TOAST system (i.e. to reduce the
rate of the unclassified group). It was also developed
to improve interclass reliability in IS classification by
providing interclinician language cohesion in interpreting
stroke-related features (2,4–6).
In studies involving multiple international centers,
it was stated that the CCS indicated a high level of
harmonization among evaluators (1,2,4–7,9–11). We
aimed to investigate the concordance between evaluators
who classify IS using either TOAST or the modern CCS
system. Since, in general, highly experienced evaluators are
investigated in IS studies, we aimed to create heterogeneity
among the evaluators by including both stroke specialists
(stroke neurologists) and general neurology specialists
(general neurologists) who have less experience but still
manage stroke patients in their general neurology practice.
2. Materials and methods
2.1. Study population
A total of 50 consecutive acute IS patients admitted to and
registered in the Dokuz Eylül University Hospital Stroke
Unit were recruited prospectively into the study, following
the approval of the local ethics committee.
2.2. Data collection
During the hospitalization of the patients, medical records
were registered as data files generated by two local staff

in the stroke unit and a registrar. These files included
demographic data (age, sex, etc.) and medical history,
as well as the neurological examination and results of
radiological, cardiological, and serum biochemical tests of
the patients.
The medical history included queries about
hypertension (a history of hypertension or an observed
arterial blood pressure of >140/90 mmHg), diabetes
mellitus (presence of a history of diabetes mellitus or
a fasting glucose exceeding 126 mg/dL other than that
measured during the acute phase), hyperlipidemia (positive
history of hyperlipidemia or a fasting total cholesterol
>200 mg/dL, LDL >130 mg/dL, and/or triglycerides >180
mg/dL), smoking habits, alcohol consumption, previous
transient ischemic attack or stroke, myocardial infarction
or coronary artery disease, cardiac valvular disease,
cardiomyopathy or cardiac rhythm disorders, peripheral
vascular diseases, oral contraceptives, or hormone
replacement therapy. Detailed neurological examination
and NIHSS (National Health Institute Stroke Scale) (12)
and modified Rankin Scale (mRS) (13) scores were also
recorded. The results of complete blood count, fasting
serum blood glucose, liver and renal function tests, serum
electrolytes, lipid profile, and levels of vitamin B12 and folic
acid were noted. Analysis of coagulation factors (protein
C, protein S, antithrombin III, prothrombin II, and factor
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V Leiden), and advanced vasculitis examinations (lupus
anticoagulants, anticardiolipin antibody, antinuclear
antibodies,
anti-DNA,
antineutrophil
cytoplasm
antibodies) were performed in selected cases. Brain
parenchyma (computerized tomography, CT; magnetic
resonance imaging, MRI) and vascular imaging (CT
angiography, CTA; magnetic resonance angiography, MRA;
Doppler ultrasonography, Doppler US; digital subtraction
angiography, DSA) were performed according to the
clinical status of the patient. The results of neuroimaging
were registered as reported by the radiodiagnostic
department. All radiological images were stored digitally.
Electrocardiography (ECG) was performed in all patients,
but Holter ECG and echocardiography (transthoracic,
TTE and transesophageal, TEE) were performed only if
indicated to investigate the cardiac risk factors.
2.3. Procedure
A detailed patient data file was created for each case. This
file included digital neuroimages stored in separate folders
on a USB flash memory stick, as well as neurological
examination with NIHS score and results of cardiac
and biochemical tests. These were delivered to 2 stroke
neurologists highly experienced in cerebrovascular
neurology and 2 general neurologists who manage stroke
patients within their routine general neurology practice. All
raters were from different neurology clinics, unaware of the
other evaluators and the reference opinion. The reference
opinion, from someone who did not participate in patient
care during this period, was the final decision made by the
highly experienced head of the cerebrovascular unit in the
neurology department at Dokuz Eylül University Hospital.
First, neurologists were asked to evaluate the files
according to the TOAST system within 60 days. Data files
were delivered to neurologists by cargo in groups of ten
in order not to confuse or rush them. Relevant articles
regarding the TOAST classification system were also
delivered within the first group.
Next, evaluators registered with the web-based
semiautomated CCS system at https://ccs.mgh.harvard.
edu. They were certified after successfully completing
10 disease education modules including clinical and
diagnostic tests offered by CCS version 2.0. Then
neurologists were asked to evaluate the data files according
to the CCS system. Files were randomized once again and
delivered to the neurologists in groups of ten, together with
relevant articles regarding the CCS classification system.
After all data were collected, each neurologist was
assessed for compliance with the reference opinion
according to both the TOAST and the CCS systems. In
addition, neurologists were assessed in pairs for compliance
and finally the concordance among all was calculated.
2.4. Statistical analysis
Statistical analysis was performed using SPSS 15.0
for Windows. Diagnostic accuracy using different
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classification systems between the neurologists was
determined by the kappa (ĸ) statistic. A ĸ-value of 0.80
and above was considered as excellent, 0.61–0.80 as strong,
and 0.41–0.60 as moderate compliance. Each CCS system
was categorized in 5, 8, and 16 categories to perform
comparisons between groups. The Fleiss kappa method
was used for multiple compliance analyses of more than
two evaluators.
3. Results
3.1. Clinical characteristics
Twenty out of 50 patients were women with a mean age
of 70 (26–92) years. Risk factors for IS and demographic
data are summarized in Table 2. Diffusion MRI could not
be performed due to a pacemaker in one case and unstable
vital findings in three cases. Vascular evaluation could not
be performed due to unstable vital signs in one patient
(2%). Stenosis was defined according to North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
criteria as narrowing in the vessel lumen by at least 50%.
Extracranial arteries were occluded in 4 cases (8%) and
stenosis was found in 9 cases (18%). Intracranial arteries
were occluded in 6 cases (12%) and stenosis was found in
4 cases (8%). The vascular evaluation of one venous infarct
case revealed occlusion of the sinus rectus. Routine ECG
was performed in all cases and cardiac arrhythmia was
detected in 18. One patient was diagnosed with paroxysmal
AF in rhythm Holter ECG. The risk of cardioembolism
was high in 19 cases (38%) and low in 6 cases (12%).
3.2. TOAST and CCS comparison
The compliance of both stroke neurologists with the
reference opinion was strong (ĸ: 0.77 and 0.67 for each
neurologist) in the TOAST classification. On the contrary,
their compliance was excellent for 5 subtypes in the CCS
classification (ĸ: 0.83 and 0.86 for each; Table 3). The
compliance of general neurologists with the reference
opinion was also strong for the TOAST classification (ĸ:
0.76 and 0.78 for each). According to the CCS classification,
compliance of the first neurologist was strong (ĸ: 0.70),
while it was excellent for the second neurologist (ĸ: 0.89).
Although the intrarater reliability was higher in the
CCS than the TOAST system, the diagnostic compliance
was still strong for both classification systems. When all
four neurologists were considered, their compliance was
moderate (ĸ: 0.59) in the TOAST system, whereas it was
strong in the CCS system (ĸ: 0.75).
Subtype assignments for each neurologist were
examined in the TOAST and CCS classifications (Table 4).
The highest compliance was for ‘cardioembolism’ (91%)
and ‘other identified causes’ (78.3%).
Table 5 summarizes the compliance rates including
all 5 evaluations (2 stroke neurologists, 2 general
neurologists, and the reference opinion) of 50 patients
using 2 classification systems (500 evaluations in total).
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Table 2. Demographic data of ischemic stroke patients.
Demographic data

n

%

20

40

Hypertension

33

66

Dyslipidemia

24

48

Age (mean: 70, range: 26–92)
Sex (female)
Risk factors

Cardiac arrhythmia

19

38

Diabetes mellitus

19

38

Cerebrovascular disease history

15

30

Smoking

23

46

Coronary artery/valvular heart disease

24

48

Cerebrovascular atherosclerosis

14

28

Hypercoagulability

5

10

Other (malignancy, family history of stroke, etc.)

6

12

Brain CT

50

100

Brain MRI

9

18

Diffusion MRI

46

92

39

78

Brain imaging

Vascular imaging
CT angiography
MRI angiography

5

10

DSA

5

10

Cervical Doppler

4

8

49

98

Infarct area
Arterial infarct
Isolated ACA infarct

2

4

Isolated MCA infarct

21

42

Isolated PCA infarct

3

6

Isolated vertebrobasilar infarct

6

12

Multiple area infarcts

7

14

Border zone (watershed) infarcts

10

20

1

2

50

100

Venous infarct
Cardiac examinations
ECG
Holter ECG

1

2

Transthoracic ECO

25

50

Transesophageal ECO

3

6

CT: Computerized tomography, MRI: magnetic resonance
imaging, DSA: four system angiography, ASA: anterior cerebral
artery, OSA: middle cerebral artery, PSA: posterior cerebral
artery, ECG: electrocardiography, ECO: echocardiography.

The rate of consensus (full compliance) was 44% in both
TOAST and the CCS. The rate of full compliance with the
CCS was 26% in cases where there was no consensus in
TOAST.
The total number of cases in the ‘undetermined etiology’
group was 73 (29.2%) in the TOAST classification and
54 (21.6%) in the CCS classification. The ‘undetermined
etiology’ in TOAST decreased by 26% when the CCS
system was used (Table 6) (this situation has been discussed
in the context of patients in Figures 1 and 2).
4. Discussion
In this study, the traditional TOAST system and the newer
CCS system were used to investigate the concordance
between stroke neurologists and general neurologists.
In a study published by Ay et al. in 2007, the compliance
rates of clinicians (neurologists specialized in stroke)
were examined in all subgroups of the CCS (5). Perfect
compliance for each group was obtained; however, the
compliance rate decreased in parallel with the increasing
number of subgroups. In the study conducted by Arsava et
al. in 2010, 15 neurologists specialized in stroke, working
in 13 centers in 8 countries, participated in the CCS
reliability study, which reported ‘perfect’ compliance for
CCS-5 subtypes, while compliance remained at the ‘strong’
level for CCS-8 and CCS-16 subtypes (6). In comparison
with the 2007 study, the reduction in compliance in CCS
subtype assignments could be explained by the reduction
in the reliability ratio due to the increasing number of
evaluators in kappa compliance analysis. High compliance
in both studies might be due to the fact that all evaluations
were performed between stroke neurologists.
In this study, evaluators were examined in two
categories. The compliance between two stroke
neurologists was higher for CCS-5 and CCS-8 when
compared to TOAST. Similarly, the compliance between
two general neurologists was also higher in the CCS. In
other words, using the CCS system after TOAST increased
the compliance level from ‘strong’ to ‘close to perfect’ in
both groups. It is not surprising that the CCS-16 subtype
had lower compliance than CCS-5 and CCS-8 subtypes, as
it is known that compliance decreases with the increasing
number of options in accordance with the principles of
kappa compliance analysis.
When the compliance between all four evaluators
was examined, the ĸ-value increased from 0.59 (TOAST)
to 0.75 and 0.73 in the assignment of CCS-5 and CCS-8
subtypes, respectively. In other words, transition from
moderate to strong compliance was achieved. In general,
evaluations in pairs were reported in the literature in
regards to the CCS system. In our study, although the
quadruple evaluation showed lower compliance, ĸ-values
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Table 3. Compliance of evaluators according to TOAST and CCS subtypes.
S1 vs. R

S2 vs. R

G1 vs. R

G2 vs. R

S1 vs. S2

G1 vs. G2

S vs. G

TOAST

K
(95% CI)

0.77
(0.60–0.94)

0.67
(0.52–0.83)

0.76
0.78
(0.60–0.91) (0.61–0.94)

0.61
(0.45– 0.77)

0.64
(0.48–0.80)

0.59
(0.52–0.65)

CCS-5

K
(95% CI)

0.83
(0.68–0.99)

0.86
(0.71–1.00)

0.70
0.89
(0.55–0.86) (0.73–1.00)

0.78
(0.62 – 0.94)

0.75
(0.60–0.91)

0.75
(0.68–0.81)

CCS-8

K
(95% CI)

0.84
(0.69–0.99)

0.84
(0.69–0.99)

0.71
0.86
(0.57–0.85) (0.72–1.00)

0.73
(0.59 – 0.88)

0.74
(0.60–0.88)

0.73
(0.67–0.78)

CCS-16

K
(95% CI)

0.68
(0.57–0.80)

0.65
(0.54–0.75)

0.55
0.78
(0.45–0.65) (0.67–0.89)

0.52
(0.41 – 0.63)

0.53
(0.42–0.63)

0.53
(0.49–0.58)

K: Kappa value, CI: confidence interval, S: stroke neurologists, G: general neurologists, S1-S2: stroke neurologist 1-2, G1-G2:
general neurologist 1-2, R: reference opinion.

Table 4. According to TOAST and CCS classifications, the
evaluators’ internal compliance, mean and median values.

Table 6. Undetermined group analysis for subtyping according
to TOAST and CCS.

LAA

CE

SVO

OC

UE

Undetermined group

%

%

%

%

%

TOAST

S1

75

90

0

66.7

83.3

S2

66.7

100

100

100

54.5

S1

G1

70

89.5

33.3

100

58.3

S2

G2

58.3

85.7

66.7

50

80

G1

R

76.9

90

75

75

88.9

Average

69.9

91

55

78.3

73

Median

70

90

66.7

75

80

LAA, Large artery atherosclerosis; CE, cardioembolism; SVO,
small vessel occlusion; OC, other causes; UE, undetermined
etiology; S1-S2: stroke neurologist 1-2, G1-G2: general
neurologist 1-2, R: reference opinion.

Table 5. Compliance analysis for subtyping according to TOAST
and CCS.
Compliance analysis

n

%

Noncompliant in TOAST, full compliance in CSS
Noncompliant in CSS, full compliance in TOAST
Full compliance in TOAST and CSS
No compliance in TOAST and CSS
Increased TOAST compliance in CSS

13
2
22
11
2

26
4
44
22
4

Total

50

100

174

n

CCS

Change

%

n

%

%

17

34

12

24

29.4

9

18

11

22

–22.2

13

26

12

24

7.7

G2

19

38

10

20

47.3

R

15

30

9

18

40

Total

73

29.2

54

21.6

26.02

S1-S2: Stroke neurologist 1-2, G1-G2: general neurologist 1-2, R:
reference opinion.

still showed ‘strong compliance’ between pairs. There was
no perfect compliance for any subtype of CCS, similar to
the studies conducted in 2007 and 2010 (5,6).
In 2012, Lanfranconi et al. (14) published a study
comparing the TOAST and CCS systems in which 690
patients were evaluated. According to this study, perfect
compliance was found for both classification systems.
However, the discriminating feature of this study was that
a single evaluator tested the two systems and reported
perfect compliance. This result reflects the fact that
compliance will increase as the number of evaluators
decreases. Similarly, in our study, when looking at the
intrarater compliance in the two systems, compliance
was found to be ‘strong’ and ‘strong, close to perfect’ for
TOAST and CCS, respectively (ĸ: 0.62 and 0.78).
The compliance of each stroke neurologist with
the reference opinion in CCS-5 and CCS-8 subtypes

KUNT et al. / Turk J Med Sci

Figure 1. Etiologic and phenotypic subtype of stroke etiology according to CCS classification: as an example case in which language
consensus between CCS and clinicians is provided is a 49-year-old patient, with internal border zone infarctions on the left, complete
occlusion after left internal carotid artery bifurcation, mild SEK (spontaneous ECO contrast), heterozygous factor V Leiden mutation,
and homozygous MTHFR A1298C mutation, which can be arguable. When assessed according to the TOAST classification (including the
reference opinion), the three evaluators identified the etiologic cause of stroke as major arterial atherosclerosis. Two evaluators included
the patient in the ‘unaccountable’ group due to the presence of two mechanisms (large artery atherosclerosis and other established
causes). Later, when data were entered according to the CCS classification, two obvious causes (large artery atherosclerosis and other
established causes) and a possible cause (cardioembolism) were detected. Language consensus was provided among researchers in the
CCS, and five evaluators identified ‘large artery atherosclerosis’ as the stroke’s cause.

Figure 2. Etiologic and phenotypic subtype of stroke etiology according to CCS classification: a 92-year-old patient referred to the
dysarthria-incompetent hand clinic with a lacunar infarct in the right corona radiata localization and atrial fibrillation was identified
by an evaluator as having cardioembolism and one as small artery occlusion when assessed by TOAST (including reference opinion).
The three evaluators made assignments that could not be determined by mentioning the possible presence of two possible mechanisms
(cardioembolism and small artery occlusion) that could lead to a stroke. When the data were entered according to the CCS classification,
two obvious causes (cardioembolism and small artery occlusion) were identified, but with the automated system in which the clinical
features of the disease were included, the stroke cause was identified as ‘possible vascular disease’ by five evaluators and full compliance
was achieved.

was superior to that of the TOAST classification. The
assessment of compliance of general neurologists with the
reference opinion revealed excellent compliance of the
first neurologist in CCS-5 and CCS-8 subtypes compared

with TOAST. However, the second neurologist showed a
lower compliance rate in subgroup assignments for CCS5 and CCS-8. While the evaluator remained in strong
compliance with the reference opinion in both systems, the
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ĸ-value was 0.76 in TOAST and 0.70 in the CCS-5 system.
Analyses revealed that the major cause of the mistakes was
the lack of entry of the identified etiological information
into the system.
Both in TOAST and the CCS, interrater compliance
was reviewed according to the main subgroups. The highest
compliance was detected in subtypes of ‘cardioembolism’
and ‘other identified causes’. Given the fact that treatment
of cardioembolic stroke and other established causes
differs from other categories, one of the advantages of
the CCS system would be the better recognition of these
subtypes. Unlike our study, the ‘undetermined etiology’
group and ‘cardioembolism’ were reported as the most
frequent etiologies in the studies of Lanfranconi et al.
and a prospective cohort study in North Dublin (10,14).
Moreover, in the NINDS SiGN study, which was a pooled
analysis of 20 studies that enrolled 13,596 patients, the
highest compliance between the evaluators was in ‘great
artery atherosclerosis’ while the lowest compliance was
found in ‘small artery occlusion’ (7).
One of the main objectives of the CCS classification
is to reduce the number of patients that cannot be
identified in TOAST due to multiple etiologies (2,4–6).
In 2005, Ay et al. compared TOAST with the SSS-TOAST
system, the ancestor of CCS, and reported a decrease in
the ‘undetermined etiology’ group from 38%–40% to 4%
(4). Likewise, Arsava et al. reported that 22% of ischemic
stroke cases had multiple etiologies; however, this rate
was between 0% and 8% with the CCS (6). Classification
with the CCS decreased the number of the ‘undetermined
etiology’ group in the North Dublin study by 33.3% (10)
and in Gökcal et al.’s study by 26% (15) when compared
with TOAST. Arsava et al.’s study (1816 patients included)
in 2017 also reported that the size of the undetermined
category was 33% by the CCS and 53% by TOAST (16). On
the contrary, Lanfranconi et al. reported that 35 out of the
204 cases that were unaccountable with TOAST had been
assigned to a subtype in the CCS, whereas 32 out of 200

cases without a definite etiology with the CCS had been
assigned to a subtype with TOAST (14). In conclusion,
they stated that there was no significant difference in the
‘undetermined etiology’ group between TOAST and the
CCS. In our study, a 26% reduction was detected in CCS
classification compared with TOAST in the proportion of
the ‘undetermined etiology’ group.
As a result, the CCS system improved compliance
both in stroke neurologists and general neurologists when
compared to TOAST in the classification of ischemic
stroke. In addition, there was a decline in the proportion
of unexplained cases in the CCS classification. The highest
compliance was detected in subtypes of ‘cardioembolism’
and stroke due to ‘other identified causes’.
This study has some major limitations. First, we have
a small sample size, which limited our statistical power
to evaluate the agreement between the classification
systems studied. However, this study has made a major
improvement in the etiological classification of ischemic
stroke compared to the stroke neurologist and general
neurologist. The other limitation of our study is that not
all patients were evaluated by echocardiography and 24-h
Holter ECG monitoring, which might have limited the
identification of cardioembolism.
In conclusion, correct identification of ischemic stroke
subtype is the most important issue in approaching stroke
patients, both for medical management and in ensuring
language consensus among researchers in multicenter
clinical trials. This study made a major innovation
in the comparison of stroke neurologists and general
neurologists, as well as contributing the data of a stroke
unit from Turkey to the literature. The results of this
study suggest that the automatic, evidence-based, and
easily reproducible CCS system could be superior to the
TOAST system for accurate subtyping. The CCS could
be recommended in both routine clinical management of
stroke patients and patient selection in multicenter clinical
trials instead of TOAST.
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